Basit öğe kaydını göster

dc.contributor.authorErsoy, Suleyman
dc.contributor.authorBenli, Ali Ramazan
dc.contributor.authorEngin, Velittin Selçuk
dc.contributor.authorPala, Emin
dc.date.accessioned2022-07-04T16:48:16Z
dc.date.available2022-07-04T16:48:16Z
dc.identifier.citationPala E., Ersoy S., Engin V. S. , Benli A. R. , "Effectiveness of STOPP/START criteria in primary prevention of polypharmacy and under-treatment in older patients", Therapies, 2021
dc.identifier.issn0040-5957
dc.identifier.othervv_1032021
dc.identifier.otherav_fa58d496-24de-462f-810d-62c12aab3026
dc.identifier.urihttp://hdl.handle.net/20.500.12627/185456
dc.identifier.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85120646832&origin=inward
dc.identifier.urihttps://doi.org/10.1016/j.therap.2021.07.003
dc.description.abstract© 2021 Société française de pharmacologie et de thérapeutiqueAim of the study: STOPP/START criteria appear to be a useful tool to curb inappropriate prescribing (IP), which encompasses errors of both, over and under-treatment. This study aimed to find out whether application of STOPP/START reduces the IP effectively in primary care. Methods: This prospective cross-sectional study was conducted in two family health centers (FHCs) in Istanbul. All older adults who applied to FHCs between 01-07-2018 and 01-07-2020 were enrolled. The potential inappropriate medications (PIMs) and potential prescription omissions (PPOs) were identified according to STOPP/START version 2 criteria. Mean drug consumptions before and after STOPP/START were compared using Student's t-test. Results: Among 1023 participants there were 626 females and 397 males. The mean age was 73.33 ± 7.30 years. The number of the patients seen at FHCs was 657 (64.2%) while 366 (35.8%) of them were visited at home. Of the patients, 383 (37.8) were 75 years old or older and 631 (62.2%) of them were under 75. Overall number of drugs consumed per patient was 5.49 ± 3.93 while it was 6.01 ± 3.71 and 4.55 ± 4.138 for outpatients and home patients respectively (p < 0.001). By application of STOPP criteria, among the 5616 medications consumed by the overall patients, 881(%15.6) of them were found to be potentially inappropriate. 424 (41.4%) patients were using at least one PIM. This ratio was 354 (53.8%) in outpatients and 70 (19%) in home patients. START criteria identified 380 (%7.4) PPOs. There were 246 (24.0%) patients with at least with one PPO; 155 (42.3%) of whom were home patients and 91 (13.8%) were outpatients. Regarding the age groups; PIM ratio was 35.5% in patients under 75 and 52.1% over 75 whereas PPO ratio was 22.5% under 75 and 26.8% over 75. Conclusion: This study supports the data reporting the effectiveness of STOPP/START criteria in primary care units in implementing appropriate prescription criteria.
dc.language.isoeng
dc.subjectPharmacology (medical)
dc.subjectHealth Sciences
dc.subjectYaşam Bilimleri
dc.subjectTemel Bilimler
dc.subjectEczacılık
dc.subjectSağlık Bilimleri
dc.subjectFARMAKOLOJİ VE ECZACILIK
dc.subjectFarmakoloji ve Toksikoloji
dc.subjectYaşam Bilimleri (LIFE)
dc.subjectTemel Eczacılık Bilimleri
dc.titleEffectiveness of STOPP/START criteria in primary prevention of polypharmacy and under-treatment in older patients
dc.typeMakale
dc.relation.journalTherapies
dc.contributor.departmentUniversity of Health Sciences , ,
dc.contributor.firstauthorID3403867


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster